WIXOM, Mich.--(BUSINESS WIRE)--July 16, 2026-- 

Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it will release its financial and operational results for the second quarter ended June 30, 2026 on Thursday, August 13, 2026. The Company will issue a press release at 6:00 a.m. ET followed by a live webcast at 8:00 a.m. ET.

WEBCAST DETAILS

Date: Thursday, August 13, 2026

Time: 8:00 a.m. ET

Webcast and Replay: www.RockwellMed.com/Results

Speakers:

   --  Mark Strobeck, Ph.D. -- President and Chief Executive Officer 
 
   --  Jesse Neri -- SVP, Chief Financial Officer 

Format: Discussion of second quarter 2026 financial and operational results followed by Q&A.

ABOUT ROCKWELL MEDICAL

Rockwell Medical, Inc. (Nasdaq: RMTI) is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. Rockwell Medical's mission is to provide dialysis clinics and the patients they serve with the highest quality products supported by the best customer service in the industry. Rockwell is focused on innovative, long-term growth strategies that enhance its products, its processes, and its people, enabling the Company to deliver exceptional value to the healthcare system and provide a positive impact on the lives of hemodialysis patients. Hemodialysis is the most common form of end-stage kidney disease treatment and is typically performed in freestanding outpatient dialysis centers, hospital-based outpatient centers, skilled nursing facilities, or a patient's home. Rockwell Medical's products are vital to vulnerable patients with end-stage kidney disease, and the Company is relentless in providing unmatched reliability and customer service. Certified as a Great Place to Work$(R)$ four years in a row (2023-2026) and named Fortune Best Workplaces in Manufacturing & Production$(TM)$ in 2024 and 2025, Rockwell Medical is Driven to Deliver Life-Sustaining Dialysis Solutions(TM). For more information, visit www.rockwellmed.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260716198228/en/

 
    CONTACT:    (248) 432-1362 

IR@RockwellMed.com

(END) Dow Jones Newswires

July 16, 2026 06:02 ET